Brokerages Set DaVita Inc. (NYSE:DVA) Price Target at $166.33

Shares of DaVita Inc. (NYSE:DVA - Get Free Report) have earned an average rating of "Hold" from the six brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $166.33.

A number of brokerages have recently issued reports on DVA. Barclays upped their price target on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st.

DaVita Stock Up 0.4 %

DaVita stock traded up $0.63 during midday trading on Friday, hitting $150.00. 902,971 shares of the company's stock were exchanged, compared to its average volume of 924,417. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita has a 12 month low of $125.64 and a 12 month high of $179.60. The firm has a 50-day moving average of $158.80 and a two-hundred day moving average of $157.61. The company has a market cap of $12.00 billion, a PE ratio of 13.97, a P/E/G ratio of 1.07 and a beta of 0.99.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, analysts expect that DaVita will post 10.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DaVita

Several hedge funds have recently made changes to their positions in DVA. Copia Wealth Management acquired a new position in shares of DaVita in the 4th quarter valued at $30,000. SBI Securities Co. Ltd. acquired a new position in shares of DaVita in the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC increased its position in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after acquiring an additional 100 shares during the period. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the 4th quarter worth about $55,000. Finally, Quarry LP acquired a new stake in DaVita during the 3rd quarter worth about $60,000. 90.12% of the stock is owned by institutional investors and hedge funds.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.